User profiles for F.A. Angarita

Fernando A. Angarita, MD, MSc, FRCSC

University of Toronto / Roswell Park Comprehensive Cancer Center
Verified email at mail.utoronto.ca
Cited by 1537

Oncolytic vaccinia virus disrupts tumor-associated vasculature in humans

…, TH Hwang, J Heo, M Cho, H Chen, FA Angarita… - Cancer research, 2013 - AACR
Efforts to selectively target and disrupt established tumor vasculature have largely failed to
date. We hypothesized that a vaccinia virus engineered to target cells with activation of the ras…

Robot-assisted nipple-sparing mastectomy: systematic review

FA Angarita, M Castelo, M Englesakis… - Journal of British …, 2020 - academic.oup.com
Background The growing volume of studies of robot-assisted nipple-sparing mastectomy
requires critical assessment. This review synthesizes the data on safety, feasibility, oncological …

Management of complex polyps of the colon and rectum

FA Angarita, AE Feinberg, SM Feinberg… - International journal of …, 2018 - Springer
Puprpose Benign polyps that are technically challenging and unsafe to remove via
polypectomy are known as complex polyps. Concerns regarding safety and completeness of …

[HTML][HTML] Abundance of regulatory T cell (Treg) as a predictive biomarker for neoadjuvant chemotherapy in triple-negative breast cancer

M Oshi, M Asaoka, Y Tokumaru, FA Angarita, L Yan… - Cancers, 2020 - mdpi.com
Simple Summary Regulatory CD4 + T cell (Treg) is one of the suppressive immune cells, but
data on its clinical relevance in large human breast cancer cohort is limited. Abundance of …

Mounting a strategic offense: fighting tumor vasculature with oncolytic viruses

FA Angarita, SA Acuna, K Ottolino-Perry… - Trends in molecular …, 2013 - cell.com
Blood supply within a tumor drives progression and ultimately allows for metastasis. Many
anticancer therapies target tumor vasculature, but their individual effectiveness is limited …

[PDF][PDF] VEGF-mediated induction of PRD1-BF1/Blimp1 expression sensitizes tumor vasculature to oncolytic virus infection

R Arulanandam, C Batenchuk, FA Angarita… - Cancer Cell, 2015 - cell.com
Oncolytic viruses designed to attack malignant cells can in addition infect and destroy tumor
vascular endothelial cells. We show here that this expanded tropism of oncolytic vaccinia …

[HTML][HTML] Locally-advanced primary neuroendocrine carcinoma of the breast: case report and review of the literature

FA Angarita, JL Rodríguez, E Meek… - World journal of surgical …, 2013 - Springer
Background Primary neuroendocrine carcinoma of the breast is a heterogeneous group of
rare tumors with positive immunoreactivity to neuroendocrine markers in at least 50% of cells. …

[HTML][HTML] Adipogenesis in triple-negative breast cancer is associated with unfavorable tumor immune microenvironment and with worse survival

M Oshi, Y Tokumaru, FA Angarita, L Lee, L Yan… - Scientific reports, 2021 - nature.com
Cancer-associated adipocytes are known to cause inflammation; however, the role of
adipogenesis, the formation of adipocytes, in breast cancer is unclear. We hypothesized that intra-…

[HTML][HTML] Degree of early estrogen response predict survival after endocrine therapy in primary and metastatic ER-positive breast cancer

M Oshi, Y Tokumaru, FA Angarita, L Yan, R Matsuyama… - Cancers, 2020 - mdpi.com
Simple Summary Over 70% of breast cancer patients in the US have estrogen receptor (ER)-positive
tumors. A better predictive biomarker of endocrine therapy would be useful to …

[HTML][HTML] Low intratumoral genetic neutrophil-to-lymphocyte ratio (NLR) is associated with favorable tumor immune microenvironment and with survival in triple …

…, V Murthy, W Tian, L Yan, FA Angarita… - American Journal of …, 2021 - ncbi.nlm.nih.gov
Patients with triple negative breast cancer (TNBC) have a poor prognosis. A novel prognostic
biomarker may guide management by appropriately selecting patients for particular …